A Wicklow woman whose father died after suffering from idiopathic pulmonary fibrosis will host a memorial run this April to raise awareness about the disease and vital funds for the Irish Lung ...

YORK, Maine – York Hospital announced that Marta Kokoszynska, MD, has joined the medical staff as Medical Director of ...

New England Journal of Medicine Publishes eNRGy Trial Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause of bacterial pneumonia for them. Indeed, it was the most frequently isolated ...

Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis, with a ...

The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...

Native Americans face the longest travel times, even after accounting for distances in rural areas, according to results of a ...

The publication reviews the results of 204 patients with 12 tumor types enrolled and treated on the eNRGy study, concluding “Zenocutuzumab demonstrated durable efficacy in patients with advanced NRG1+ ...

The biggest challenge in training the next generation of respiratory therapists is getting them to engage in "critical ...

Positive Feedback on Phase III Trial Design LONDON, Feb. 5, 2025 /PRNewswire/ -- Serac Healthcare Limited (Serac Healthcare ...

Learn more about whether Alkermes plc or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.